259
Participants
Start Date
November 2, 2005
Primary Completion Date
November 7, 2006
Study Completion Date
November 7, 2006
GSK questionnaire
GSK questionnaire will demonstrate the validity, reliability and responsiveness as a tool for measuring subject-reported outcomes during an acute exacerbation of chronic obstructive pulmonary disease.
St. George's Respiratory Questionnaire
The SGRQ is a 50-item questionnaire with 76 weighted responses. It provides a Total score and three component scores: Symptoms (distress caused by respiratory symptoms), Activity (physical activities that cause or are limited by breathlessness), and Impacts (social and psychological effects of the disease). The Total score and each of the SGRQ sub-scores are scored from 0 to 100 where 0 indicates best and 100 indicates worst health.
Acute Short Form 12 version 2
The Acute SF-12v2 is a multipurpose short-form questionnaire with only 12 questions with two summary scores, the SF-12 Physical Component Summary (PCS-12) and the SF-12 Mental Component Summary (MCS-12). The scoring range for the PCS-12 and MCS-12 is 0 to 100, with a lower score indicating a poorer level of health
Global Efficacy questionnaire
Global Efficacy questionnaire will be administered in an electronic form to validate test-retest reliability, responsiveness and minimum important difference (MID)
GSK Investigational Site, New York
GSK Investigational Site, New York
GSK Investigational Site, New York
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Great Neck
GSK Investigational Site, Mineola
GSK Investigational Site, Kingston
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Potsdam
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Rüdersdorf
GSK Investigational Site, Genoa
GSK Investigational Site, Allentown
GSK Investigational Site, Allentown
GSK Investigational Site, Philadelphia
GSK Investigational Site, Audubon
GSK Investigational Site, King of Prussia
GSK Investigational Site, Plymouth Meeting
GSK Investigational Site, Rozzano (MI)
GSK Investigational Site, Hamburg
GSK Investigational Site, Towson
GSK Investigational Site, Geesthacht
GSK Investigational Site, Hamburg
GSK Investigational Site, Richmond
GSK Investigational Site, Wahlstedt
GSK Investigational Site, Lynchburg
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Elizabeth City
GSK Investigational Site, Spartanburg
GSK Investigational Site, Summerville
GSK Investigational Site, Greer
GSK Investigational Site, Decatur
GSK Investigational Site, Austell
GSK Investigational Site, Atlanta
GSK Investigational Site, Pensacola
GSK Investigational Site, Pensacola
GSK Investigational Site, Melbourne
GSK Investigational Site, Tampa
GSK Investigational Site, Sarasota
GSK Investigational Site, Cittadella (PD)
GSK Investigational Site, Hueytown
GSK Investigational Site, Birmingham
GSK Investigational Site, Birmingham
GSK Investigational Site, Birmingham
GSK Investigational Site, Jasper
GSK Investigational Site, Clarksville
GSK Investigational Site, Morristown
GSK Investigational Site, Picayune
GSK Investigational Site, Solingen
GSK Investigational Site, Columbus
GSK Investigational Site, Bochum
GSK Investigational Site, Cincinnati
GSK Investigational Site, Gelsenkirchen
GSK Investigational Site, South Bend
GSK Investigational Site, Newburgh
GSK Investigational Site, Detroit
GSK Investigational Site, DeWitt
GSK Investigational Site, Plainwell
GSK Investigational Site, Richland
GSK Investigational Site, Saint Joseph
GSK Investigational Site, Waterloo
GSK Investigational Site, Dubuque
GSK Investigational Site, Düren
GSK Investigational Site, Bonn
GSK Investigational Site, Bonn
GSK Investigational Site, Euskirchen
GSK Investigational Site, Pisa
GSK Investigational Site, Lüdenscheid
GSK Investigational Site, North Chicago
GSK Investigational Site, Chicago
GSK Investigational Site, Peoria
GSK Investigational Site, Springfield
GSK Investigational Site, Kirkwood
GSK Investigational Site, Saint Charles
GSK Investigational Site, Kansas City
GSK Investigational Site, Columbia
GSK Investigational Site, Omaha
GSK Investigational Site, Schwetzingen
GSK Investigational Site, Weinheim
GSK Investigational Site, Bari
GSK Investigational Site, Covington
GSK Investigational Site, Lafayette
GSK Investigational Site, Sunset
GSK Investigational Site, Baton Rouge
GSK Investigational Site, Foggia
GSK Investigational Site, Corsicana
GSK Investigational Site, Houston
GSK Investigational Site, San Antonio
GSK Investigational Site, Wheat Ridge
GSK Investigational Site, Denver
GSK Investigational Site, Munich
GSK Investigational Site, Fort Collins
GSK Investigational Site, Caserta
GSK Investigational Site, Munich
GSK Investigational Site, Telese Terme (BN)
GSK Investigational Site, Eboli (SA)
GSK Investigational Site, Salerno
GSK Investigational Site, Bad Woerrishofen
GSK Investigational Site, Landsberg am Lech
GSK Investigational Site, Palermo
GSK Investigational Site, San Diego
GSK Investigational Site, Rancho Mirage
GSK Investigational Site, Riverside
GSK Investigational Site, Kötzting
GSK Investigational Site, Hartford
GSK Investigational Site, Hartford
GSK Investigational Site, Hines
GSK Investigational Site, Auburn
GSK Investigational Site, East Brunswick
GSK Investigational Site, Summit
GSK Investigational Site, Buffalo
GSK Investigational Site, East Providence
GSK Investigational Site, Charleston
GSK Investigational Site, San Martino in Tregnano (Spoleto, PG)
GSK Investigational Site, Spoleto (PG)
GSK Investigational Site, San Sisto (PG)
Lead Sponsor
GlaxoSmithKline
INDUSTRY